Brennan MF, Antonescu CR, Alektiar KM, Maki RG. Primary sarcomas of the breast. Management of Soft Tissue Sarcoma. 2nd ed. Cham, Switzerland: Springer; 2016. 344-8.
Tan BY, Acs G, Apple SK, Badve S, Bleiweiss IJ, Brogi E, et al. Phyllodes tumours of the breast: a consensus review. Histopathology. 2016 Jan. 68 (1):5-21. [Medline].
Parker SJ, Harries SA. Phyllodes tumours. Postgrad Med J. 2001 Jul. 77 (909):428-35. [Medline]. [Full Text].
Jones AM, Mitter R, Poulsom R, Gillett C, Hanby AM, Tomlinson IP, et al. mRNA expression profiling of phyllodes tumours of the breast: identification of genes important in the development of borderline and malignant phyllodes tumours. J Pathol. 2008 Dec. 216 (4):408-17. [Medline].
Abe M, Miyata S, Nishimura S, Iijima K, Makita M, Akiyama F, et al. Malignant transformation of breast fibroadenoma to malignant phyllodes tumor: long-term outcome of 36 malignant phyllodes tumors. Breast Cancer. 2011 Oct. 18 (4):268-72. [Medline].
Brooks HL, Priolo S, Waxman. Cystosarcoma phylloides: a case report of an 11-year survival and review of surgical experience. Contemp Surg. 1998. 53:169-72.
Yohe S, Yeh IT. "Missed" diagnoses of phyllodes tumor on breast biopsy: pathologic clues to its recognition. Int J Surg Pathol. 2008 Apr. 16 (2):137-42. [Medline].
Pezner RD, Schultheiss TE, Paz IB. Malignant phyllodes tumor of the breast: local control rates with surgery alone. Int J Radiat Oncol Biol Phys. 2008 Jul 1. 71 (3):710-3. [Medline].
Jones AM, Mitter R, Springall R, Graham T, Winter E, Gillett C, et al. A comprehensive genetic profile of phyllodes tumours of the breast detects important mutations, intra-tumoral genetic heterogeneity and new genetic changes on recurrence. J Pathol. 2008 Apr. 214 (5):533-44. [Medline].
Wei J, Tan YT, Cai YC, Yuan ZY, Yang D, Wang SS, et al. Predictive factors for the local recurrence and distant metastasis of phyllodes tumors of the breast: a retrospective analysis of 192 cases at a single center. Chin J Cancer. 2014 Oct. 33 (10):492-500. [Medline].
Rodrigues MF, Truong PT, McKevitt EC, Weir LM, Knowling MA, Wai ES. Phyllodes tumors of the breast: The British Columbia Cancer Agency experience. Cancer Radiother. 2018 Apr. 22 (2):112-119. [Medline].
Nabi J, Akhter SM, Authoy FN. A case of large phyllodes tumor causing "rupture" of the breast: a unique presentation. Case Rep Oncol Med. 2013. 2013:871292. [Medline]. [Full Text].
Jung YY, Lee YK, Koo JS. Expression of lipid metabolism-related proteins in breast phyllodes tumors. Neoplasma. 2016. 63 (2):254-62. [Medline].
Bellezza G, Prosperi E, Del Sordo R, Colella R, Rulli A, Sidoni A. IMP3 Is Strongly Expressed in Malignant Phyllodes Tumors of the Breast: An Immunohistochemical Study. Int J Surg Pathol. 2016 Feb. 24 (1):37-42. [Medline].
Al-Masri M, Darwazeh G, Sawalhi S, Mughrabi A, Sughayer M, Al-Shatti M. Phyllodes tumor of the breast: role of CD10 in predicting metastasis. Ann Surg Oncol. 2012 Apr. 19 (4):1181-4. [Medline].
Jardim DL, Conley A, Subbiah V. Comprehensive characterization of malignant phyllodes tumor by whole genomic and proteomic analysis: biological implications for targeted therapy opportunities. Orphanet J Rare Dis. 2013 Jul 30. 8:112. [Medline]. [Full Text].
Cole-Beuglet C, Soriano R, Kurtz AB, Meyer JE, Kopans DB, Goldberg BB. Ultrasound, x-ray mammography, and histopathology of cystosarcoma phylloides. Radiology. 1983 Feb. 146 (2):481-6. [Medline]. [Full Text].
Kawashima H, Miyati T, Ohno N, Ohno M, Inokuchi M, Ikeda H, et al. Differentiation between phyllodes tumours and fibroadenomas using intravoxel incoherent motion magnetic resonance imaging: comparison with conventional diffusion-weighted imaging. Br J Radiol. 2018 Apr. 91 (1084):20170687. [Medline].
Yasir S, Gamez R, Jenkins S, Visscher DW, Nassar A. Significant histologic features differentiating cellular fibroadenoma from phyllodes tumor on core needle biopsy specimens. Am J Clin Pathol. 2014 Sep. 142 (3):362-9. [Medline].
Efared B, Ebang GA, Tahiri L, Sidibé IS, Erregad F, Hammas N, et al. Phyllodes tumors of the breast: clinicopathological analysis of 106 cases from a single institution. Breast Dis. 2018. 37 (3):139-145. [Medline].
[Guideline] Bendifallah S, Canlorbe G. [Common benign breast tumors including fibroadenoma, phyllodes tumors, and papillary lesions: Guidelines]. J Gynecol Obstet Biol Reprod (Paris). 2015 Dec. 44 (10):1017-29. [Medline].
Adam MJ, Bendifallah S, Kalhorpour N, Cohen-Steiner C, Ropars L, Mahmood A, et al. Time to revise classification of phyllodes tumors of breast? Results of a French multicentric study. Eur J Surg Oncol. 2018 Nov. 44 (11):1743-1749. [Medline].
Chen WH, Cheng SP, Tzen CY, Yang TL, Jeng KS, Liu CL, et al. Surgical treatment of phyllodes tumors of the breast: retrospective review of 172 cases. J Surg Oncol. 2005 Sep 1. 91 (3):185-94. [Medline].
Contarini O, Urdaneta LF, Hagan W, Stephenson SE Jr. Cystosarcoma phylloides of the breast: a new therapeutic proposal. Am Surg. 1982 Apr. 48 (4):157-66. [Medline].
Onkendi EO, Jimenez RE, Spears GM, Harmsen WS, Ballman KV, Hieken TJ. Surgical treatment of borderline and malignant phyllodes tumors: the effect of the extent of resection and tumor characteristics on patient outcome. Ann Surg Oncol. 2014 Oct. 21 (10):3304-9. [Medline].
[Guideline] Lavoué V, Fritel X, Antoine M, Beltjens F, Bendifallah S, Boisserie-Lacroix M, et al. Clinical practice guidelines from the French College of Gynecologists and Obstetricians (CNGOF): benign breast tumors - short text. Eur J Obstet Gynecol Reprod Biol. 2016 May. 200:16-23. [Medline].
Gullett NP, Rizzo M, Johnstone PA. National surgical patterns of care for primary surgery and axillary staging of phyllodes tumors. Breast J. 2009 Jan-Feb. 15 (1):41-4. [Medline].